Skip to main content

Table 2 Review progress and workload implications during the pilot period

From: Feasibility and acceptability of living systematic reviews: results from a mixed-methods evaluation

Review topicaAnti-coagulation in people with cancer (3 related LSRs)bFruit and vegetable consumption in childrenDelayed antibiotics for respiratory infectionsZika virus and adverse neurological outcomesAdherence to guidelines in traumatic brain injuryEpidemiology of traumatic brain injury
Date ‘baseline’ review publishedLSR 1c: September 2017
LSR 2d: December 2017
LSR 3e: June 2018
September 2017September 2017February 2018October 2015November 2015
No. of studies in ‘baseline’ publicationLSR 1c: 19
LSR 2d: 7
LSR 3e: 16
No. of new studies found since ‘baseline’ publicationf5g130961418
No. of status updates since baseline reviewMonthly updates
LSR 1c: 10
LSR 2d: 7
LSR 3e: 1
No. of times review re-published072 (January and May 2018)0000
  1. No. number
  2. aEach team produced one LSR unless otherwise stated
  3. bThese three LSRs were part of a suite of LSRs that used a single search
  4. cRefers to the first in the suite of LSRs published: Parenteral anticoagulation in ambulatory patients with cancer.
  5. dRefers to the second in the suite of LSRs published: Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.
  6. eRefers to the third in the suite of LSRs published: Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
  7. fIncludes new (not ongoing) studies that were screened and found to meet the inclusion criteria for the review until the end of the pilot period
  8. gData presented for all three reviews (as appropriate, given they transitioned into living mode at different times during the pilot period) given the same search fed into all reviews and they were managed by the same author and editorial teams